## Diagnosis of Invasive Aspergillosis ### Clinical Context Invasive aspergillosis (IA) is a life-threatening opportunistic infection in severely immunocompromised patients (neutropenia, hematologic malignancy, transplant recipients). Rapid diagnosis is critical because mortality increases with treatment delay. ### Investigation of Choice: Bronchoalveolar Lavage (BAL) **Key Point:** BAL with combined galactomannan antigen detection and PCR is the gold standard for diagnosing invasive pulmonary aspergillosis when the clinical suspicion is high. ### Why BAL Is Superior | Feature | BAL | Serum Galactomannan | Sputum Culture | Serum IgG | |---------|-----|-------------------|-----------------|----------| | **Sensitivity** | 70–90% (with antigen + PCR) | 50–70% (variable) | 10–20% (poor) | Low in acute IA | | **Specificity** | High (>95%) | Moderate (85–90%) | Moderate | Not diagnostic of IA | | **Timing** | Direct sampling from site of infection | Indirect marker; delayed clearance | Colonization vs. infection unclear | Chronic/allergic aspergillosis | | **Clinical utility** | Confirms diagnosis + identifies organism | Supportive; not diagnostic alone | Colonization common; unreliable | Allergic bronchopulmonary aspergillosis | ### Diagnostic Algorithm ```mermaid flowchart TD A[Immunocompromised + Pulmonary infiltrates]:::outcome --> B{Clinical suspicion<br/>for IA high?}:::decision B -->|Yes| C[Perform BAL]:::action C --> D{Galactomannan<br/>antigen + PCR<br/>positive?}:::decision D -->|Yes| E[Invasive aspergillosis<br/>confirmed]:::outcome D -->|No| F[Repeat BAL or<br/>consider CT-guided biopsy]:::action B -->|Moderate| G[Serum galactomannan<br/>as adjunct]:::action G --> H{Positive?}:::decision H -->|Yes| I[High suspicion;<br/>proceed to BAL]:::action H -->|No| J[Low probability;<br/>consider alternatives]:::outcome ``` **High-Yield:** In immunocompromised patients with fever and pulmonary infiltrates, BAL is preferred over serum markers because it provides direct sampling from the site of infection, increasing diagnostic yield and allowing organism identification. ### Clinical Pearl **Tip:** Do not delay antifungal therapy (liposomal amphotericin B or voriconazole) while awaiting BAL results if clinical suspicion is very high (neutropenia + fever + infiltrates). Start empiric therapy and confirm diagnosis simultaneously. ### Why Serum Galactomannan Alone Is Insufficient - Sensitivity is 50–70% and varies by patient population - Antigen is cleared slowly; may be negative early in infection - Not diagnostic in isolation; requires clinical correlation - False positives occur with other molds and some bacterial infections ### Why Sputum Culture Is Inadequate - Aspergillus is a common environmental contaminant - Colonization vs. infection cannot be distinguished from culture alone - Sensitivity is only 10–20% in invasive IA - Takes 3–7 days for results ### Why Serum IgG Is Wrong - IgG antibodies develop in chronic/allergic aspergillosis, not acute invasive disease - Immunocompromised patients may not mount an antibody response - Not diagnostic for invasive aspergillosis
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.